cerebral hemorrhage
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1: Ages 18 and above 2: Confirmation of intracerebral hemorrhage by head CT and/or MRI 3: Deep intracerebral hemorrhage (including the deep cerebral tissue regions such as the subcortical zone, lateral ventricular wall, and the radiate cortex), cerebral lobe hemorrhage (cerebral cortex, cortico-subcortical junction), cerebellar hemorrhage, and brainstem hemorrhage 4: Patients with intracerebral hemorrhage within 30 days of onset (including 30 days) who have been hospitalized 5: Informed consent and general informed consent signed by the patient and family members.
Exclusion criteria
Exclusion criteria: 1: Traumatic intracerebral hemorrhage 2: Secondary intracerebral hemorrhage (caused by cerebral aneurysm, large arteriovenous malformation, smoking disease, cavernous malformation, cerebral hemangioma, hematological disorders, thromboembolic stroke, vasculitis, cerebral venous thrombosis, post-ischemic hemorrhage transformation, history of anticoagulant or antiplatelet drug use, etc.) 3: Mixed intracerebral hemorrhage (involving multiple deep and cerebral lobe hemorrhages at the onset of the disease) 4: Coexisting psychiatric disorders, renal and hepatic failure, autoimmune diseases, malignant tumors, and pregnancy 5: Other investigators deemed ineligible for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neurofunctional prognosis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Risk factor control;Compliance of recommended secondary medications;Symptomatic intracerebral hemorrhage recurrence events;All-cause mortality events; | — |
Countries
China
Contacts
Xiangya Hospital, Central South University, Kaifu District, Changsha City, Hunan Province